+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Seborrhoeic Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Seborrhoeic Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Sjogren's syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Sjogren's syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Moderate to Severe Atopic Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate to Severe Atopic Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Egg allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Egg allergy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Lung transplant rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Lung transplant rejection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
COSENTYX Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

COSENTYX Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • March 2024
  • 30 Pages
  • Global
From
TRS01 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

TRS01 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
REGN4461 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

REGN4461 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 60 Pages
  • Global
From
E-Selectin inhibitor- Pipeline Insight, 2024 - Product Thumbnail Image

E-Selectin inhibitor- Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
NF-kappa B Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

NF-kappa B Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Chemokine Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Chemokine Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
interleukin Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

interleukin Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
H Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

H Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Toll-Like Receptor Modulators - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-Like Receptor Modulators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more